Puma Biotechnology Reports Fourth Quarter and Full Year Financial Results | Business Wire
Articles about Puma Biotechnology
Puma Biotech (PBYI) Stock up as Q2 Earnings & Sales Beat
Puma Biotechnology
Biotech Stock Mailbag: Puma's Rebound Explained, TG Therapeutics Approval Debate, Aurinia Next Steps - TheStreet
Puma Biotech Stock Struggles To Find Its Footing In Crowded Oncology Space (NASDAQ:PBYI) | Seeking Alpha
Is Puma off the cancer M&A list? With Nerlyx marketing deal, some investors think so | Fierce Pharma
Goldman Recommends Selling Puma Biotech, Clovis Oncology; Cites Company-Specific, Competitive Risks
Puma Stock Jumps as Biotech Gets Good News From the FDA | Barron's
Why Puma Biotechnology, Inc. Stock Crashed 37% in March | The Motley Fool
Why Puma Biotechnology's Shares Jumped 20% on Monday | The Motley Fool
PBYI Stock Price and Chart — NASDAQ:PBYI — TradingView
Puma Biotechnology, Inc. Insider Trading & Ownership Structure - Simply Wall St
Why Puma Biotech Could Get Acquired Between July to September of This Year | BioSpace
Puma Biotech (PBYI) Inks Agreement for Takeda's Alisertib | Nasdaq
PBYI | Puma Biotechnology Inc. Stock Overview (U.S.: Nasdaq) | Barron's
Puma Biotechnology - Crunchbase Company Profile & Funding
Puma Biotechnology Surging
PUMA BIOTECHNOLOGY, INC. : PBYI Stock Price | US74587V1070 | MarketScreener
Puma Shares Soar 81% Over 2 Days - Los Angeles Business Journal
Former Puma Biotech executive gets U.S. prison term for insider trading | Reuters
Puma Biotech Stock Struggles To Find Its Footing In Crowded Oncology Space (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology, Inc. (PBYI) Stock Price Today, Quote & News | Seeking Alpha
Puma Biotech Surges, Defying Yellen
